| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 368.58 KB | Adobe PDF |
Orientador(es)
Resumo(s)
Kidney transplantation is the optimal treatment of end -stage renal disease (ESRD) improving survival and quality of life for most recipients. In our country, potential living donors have been refused due to the ABO incompatibility barrier. However, ABO -incompatible living donor kidney transplant is presently common practice in several countries with good outcomes. The authors describe a case of a 49 -year -old female patient, with chronic kidney disease due to autosomal dominant polycystic kidney disease, who had started haemodialysis 10 months before and with blood group
O. The living donor was a 53 -year -old sister with blood group B. The desensitization protocol was based on rituximab and plasmapheresis. The induction protocol used was basiliximab, tacrolimus, mofetil mycophenolate and metilprednisolone. Five days post -transplant she presented a normal graft function that remained during the eight months follow -up. This case reveals the first ABO incompatible living donor kidney transplant performed in Portugal with excellent outcome.
Descrição
Palavras-chave
ABO incompatibility kidney transplantation living donor Portugal
Contexto Educativo
Citação
Port J Nephrol Hypert 2015; 29(4): 332-337
